Company Filing History:
1 out of 1,289 
1 out of 81 
Years Active: 2016
Title: Kamal Chowdhury: Innovator in Cardiac Therapeutics
Introduction
Kamal Chowdhury is a notable inventor based in Goettingen, Germany. He has made significant contributions to the field of medicine, particularly in the area of cardiac disorders. His innovative work focuses on the therapeutic potential of microRNAs.
Latest Patents
Kamal Chowdhury holds a patent for the invention titled "miRNA-212/132 family as a therapeutic target." This invention refers to inhibitors of microRNAs, specifically miR-212 and/or miR-132, for use in medicine. The patent addresses the diagnosis, treatment, or prevention of cardiac disorders, including cardiac hypertrophy-associated or autophagic disorders. It also involves isolated nucleic acid molecules, particularly microRNAs miR-212 and/or miR-132, for use in human medicine, especially in the context of cardiac atrophy and dysfunctional autophagy.
Career Highlights
Throughout his career, Kamal Chowdhury has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and the Hannover Medical School. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kamal has collaborated with notable colleagues, including Thomas Thum and Ahmet Ucar. These partnerships have further enriched his research endeavors and have led to advancements in the understanding of cardiac health.
Conclusion
Kamal Chowdhury's innovative work in the field of cardiac therapeutics highlights the importance of microRNAs in medical science. His contributions through patents and collaborations continue to pave the way for advancements in the diagnosis and treatment of cardiac disorders.